Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Demannosylated recombinant factor VIII for the treatment of patients with haemophilia A

Demannosylated recombinant factor VIII for the treatment of patients with haemophilia A

US Patent 8802620 · Granted Aug 12, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of modified Fc fragments in immunotherapy2025
Affinity chromatography matrix2020
Methods and pharmaceutical compositions for inducing immune tolerance by mucosal2019
Recombinant or transgenic factor VII composition, each factor VII molecule havin2019
Method for preparing universal plasma2019
Recombinant or transgenic factor VII composition, each factor VII molecule havin2019
Method for purifying transgenic factor VII/VIIA2018
Method for preparing a concentrate of polyvalent immunoglobulin2017
Method for purifying or detecting a target protein2015
Thrombin-free biological adhesive and use thereof as a medicament2013
Immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies and 2012
Virally-safe factor VIII with a low content of higher multimers2011